STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

Learn why cytotoxicity test failures are common in medical devices and discover systematic approaches to identify root causes ...

However, that costs time and money, and the document looks the same as the one on the FDA Web site. Due to the lack of easily obtainable information, an engineer or regulatory affairs officer may ...

Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, ON, April 29, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology ...

Brinkman brings more than 15 years of experience in biological sciences and is known for her rigorous, clinically relevant approach to biological risk evaluation "We're thrilled to welcome Katie to ...

NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ — STEMart, a US-based provider of comprehensive services for all phases of medical device ...